How many 8-K filings has Bio-Techne Corp filed?

Bio-Techne Corp (TECH) has 11 8-K (Current Event Report) filings on record, spanning Jan 2024 to Aug 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Bio-Techne Corp 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Bio-Techne Corp 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Bio-Techne Corp (TECH) — 8-K Filings

All 8-K filings from Bio-Techne Corp. Browse 11 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (11)

Bio-Techne Files 8-K on Financials and Operations — Aug 6, 2025 Risk: low
Bio-Techne Corporation filed an 8-K on August 6, 2025, reporting on its results of operations and financial condition, other events, and financial statements an
Bio-Techne Corp Files 8-K on Financials and Operations — May 7, 2025 Risk: low
Bio-Techne Corporation filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition, as well as other events. The filing also inc
Bio-Techne Files 8-K: Regulation FD Disclosure — May 6, 2025 Risk: medium
Bio-Techne Corporation (BIO) filed an 8-K on May 6, 2025, reporting an event on April 30, 2025. The filing is a Regulation FD Disclosure, indicating it contains
Bio-Techne CFO Departs; New Directors Appointed — Mar 4, 2025 Risk: medium
Bio-Techne Corporation announced on February 26, 2025, the departure of its Chief Financial Officer, David A. Christenson. The company has appointed James M. Ko
Bio-Techne Corp Files 8-K on Operations and Personnel — Feb 5, 2025 Risk: low
Bio-Techne Corporation filed an 8-K on February 5, 2025, reporting on events as of January 30, 2025. The filing covers results of operations, financial conditio
BIO-TECHNE Corp. Files 8-K on Operations and Shareholder Votes — Oct 30, 2024 Risk: low
On October 25, 2024, BIO-TECHNE Corp. filed an 8-K report detailing the results of its operations and financial condition. The filing also includes information
Bio-Techne Corp Files 8-K on Operations and Financials — Aug 7, 2024 Risk: low
Bio-Techne Corporation filed an 8-K on August 7, 2024, reporting on its results of operations and financial condition, as well as other events. The filing also
Bio-Techne Corp Files 8-K on Operations and Financials — May 1, 2024 Risk: low
Bio-Techne Corporation filed an 8-K on May 1, 2024, reporting on its results of operations, other events, and financial statements. The filing details the compa
Bio-Techne Appoints Nobel Laureate Dr. Yamanaka to Board — Apr 30, 2024 Risk: low
Bio-Techne Corporation announced on April 24, 2024, the appointment of Dr. H. Shinya Yamanaka to its Board of Directors. Dr. Yamanaka, a Nobel Prize laureate, b
BIO-TECHNE Files 8-K on Operations & Financial Condition — Feb 1, 2024
BIO-TECHNE Corporation filed an 8-K on February 1, 2024, to report on its results of operations and financial condition, along with other events and financial s
BIO-TECHNE 8-K: Officer/Director Changes or Comp Arrangements — Jan 8, 2024
BIO-TECHNE Corporation filed an 8-K on January 8, 2024, reporting an event that occurred on January 5, 2024. This filing indicates a change in compensatory arra

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX